Klingman & Associates’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$517K Sell
1,572
-101
-6% -$36.3K 0.02% 190
2025
Q4
$588K Sell
1,673
-110
-6% -$40.1K 0.03% 174
2025
Q3
$659K Buy
1,783
+12
+0.7% +$4.64K 0.03% 157
2025
Q2
$701K Sell
1,771
-31
-2% -$11.6K 0.04% 137
2025
Q1
$671K Sell
1,802
-988
-35% -$376K 0.04% 129
2024
Q4
$1M Sell
2,790
-910
-25% -$337K 0.06% 102
2024
Q3
$1.34M Buy
3,700
+2,823
+322% +$974K 0.08% 92
2024
Q2
$298K Buy
+877
New +$297K 0.02% 192
2022
Q2
Sell
-2,117
Closed -$566K 208
2022
Q1
$566K Buy
+2,117
New +$548K 0.05% 109

Other funds holding SYK

Klingman & Associates's SYK Position: Q1 2026 in Review

Klingman & Associates reduced its Stryker (SYK) stake by 6% in Q1 2026, selling an estimated $36.3K and leaving 1,572 shares worth $517K. The position accounts for 0.02% of the portfolio, ranked #190.

Klingman & Associates first reported a position in SYK in Q1 2022 and has held it in 9 quarters since. The position peaked at $1.34M in Q3 2024. 2,293 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Klingman & Associates held 1,572 shares of Stryker worth $517K as of Q1 2026.
  • Klingman & Associates sold 101 Stryker shares in Q1 2026, an estimated $36.3K.
  • Stryker made up 0.02% of Klingman & Associates's portfolio in Q1 2026, its #190 holding.
  • Klingman & Associates first reported a position in Stryker in Q1 2022 and has held it in 9 quarters since.
  • Klingman & Associates's Stryker position peaked at $1.34M in Q3 2024.
  • 2,293 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Klingman & Associates's 13F filing for Q1 2026, filed 14 May 2026.